Abstract
Introduction
ED and LUTS affect a high proportion of male population. Although Hispanics are suspected to have a higher risk of experiencing LUTS, detailed information on its frequency and association with ED in this population is scarce.
Objective
To determine the frequency of LUTS and ED, and its correlation in Mexican males.
Methods
A cross-sectional analytical survey was answered by 1041 men. It included the International Prostate Symptom Score and the quality of life question (IPSS/QoL); International Index of Erectile Function (IIEF-5); the short form of the International Consultation of Incontinence Questionnaire (ICIQ-SF); and demographic data. For the analysis, we divided our population into 2 groups (18–39 and 40 and older), and then an exploratory correlation analysis was performed to search for significant differences among IPSS severity groups, and finally a multivariate regression model was applied.
Results
Mean age was 48.6 ± 14.5 years. One hundred twenty-three individuals (11.8 %) were asymptomatic, and 611 (58.7 %) had mild, 226 (21.7 %) had moderate, and 81 (7.8 %) had severe IPSS score. The most common symptoms were nocturia (72.4 %), increased urinary frequency (58.3 %), and slow urinary stream (42.6 %). Two hundred fifty-eight (24.7 %) complained of incontinence. Of 765 individuals, 484(63.2 %) reported some degree of ED. Severe LUTS, DM, and age were independent risk factors for ED severity.
Conclusion
LUTS and ED may represent one of the largest sources of morbidity in our population, and their association was demonstrated. Awareness on these entities should be raised, and further research is required to determine the higher frequency of LUTS and ED in Hispanics.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Abrams P, Cardozo L, Fall M et al (2002) The standardisation of terminology of lower urinary tract function: report from the standardisation sub-committee of the International Continence Society. Neurourol Urodyn 21:167
Irwin DE, Kopp ZS, Agatep B et al (2011) Worldwide prevalence estimates of lower urinary tract symptoms, overactive bladder, urinary incontinence and bladder outlet obstruction. BJU Int 108:1132
Coyne KS, Sexton CC, Thompson CL et al (2009) The prevalence of lower urinary tract symptoms (LUTS) in the USA, the UK and Sweden: results from the Epidemiology of LUTS (EpiLUTS) study. BJU Int 104:352
Ayta IA, McKinlay JB, Krane RJ (1999) The likely worldwide increase in erectile dysfunction between 1995 and 2025 and some possible policy consequences. BJU Int 84:50
Barroso-Aguirre J, Ugarte-y-Romano F, Pimentel-Nieto D (2001) Prevalence of erectile dysfunction in men 18 to 40 years in Mexico and associated risk factors. Perinatol Reprod Hum 15:254
González-Cuenca E, Villeda-Sandoval C, Sotomayor-de Zavaleta M et al (2012) Erectile dysfunction prevalence on a young population in Mexico. Rev Mex Urol 72:245
Ponholzer A, Temml C, Obermayr R et al (2004) Association between lower urinary tract symptoms and erectile dysfunction. Urology 64:772
McVary KT, Gange SN, Shore ND et al (2014) Treatment of LUTS secondary to BPH while preserving sexual function: randomized controlled study of prostatic urethral lift. J Sex Med 11:279
Enger SM, Van Den Eeeden JW, Sternefeld B et al (2006) California Men’s Health Study (CMHS): a multiethnic cohort in a managed care setting. BMC Public Health 6:172
Van Den Eeeden SK, Jun Shan, Jacobsen S et al (2012) Evaluating race/ethnic disparities in lower urinary tract symptoms (LUTS) in men. J Urol 187:185
Hartung R, Emberton M, Van Moorselaar R et al (2003) Sexual dysfunction in 3230 men with luts suggestive of BPH in Europe, Russia, Middle-East, Latin America and Asia. Eur Urol Suppl 2:27
Rosen RC, Riley A, Wagner G et al (1997) The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology 49:822
Badía X, García-Losa M, Dal-Ré R et al (1998) Validation of a harmonized Spanish version of the IPSS, evidence of equivalence with the original American scale. Urology 52:614
Zegarra L, Loza C, Perez V (2011) Psychometric validation of the international index of erectile function in patients with erectile dysfunction in Peru. Rev Peru Med Exp Salud Publica 28:477
Espuña M, Rebolledo P, Puig M (2004) Validation of the Spanish version of the international consultation on incontinence questionnaire-short form. Med Clin 122:288
OECD-UNDESA, World migration in Figures 2013. Database on immigrants in OECD and non-OECD countries: DIOC. http://www.oecd.org/els/mig/World-Migration-in-Figures.pdf. Accessed 24 May 2015
Irwin D, Milsom I, Hunskaar S et al (2006) Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study. Eur Urol 50:1306
Moreira E, Neves R, Fernandes N et al (2013) A Population-based survey of lower urinary tract symptoms (LUTS) and symptom-specific bother: results from the Brazilian LUTS epidemiology study (BLUES). World J Urol 31:1451
Kirby M, Chapple C, Jackson G et al (2013) Erectile dysfunction and lower urinary tract symptoms: a consensus on the importance of co-diagnosis. Int J Clin Pract 67:606
Song J, Shao Q, Tian Y et al (2014) Lower urinary tract symptoms, erectile dysfunction, and their correlation in men aged 50 years and above: a cross-sectional survey in Beijing. China Med Sci Monit 20:2806
Morelli A, Filippi S, Sandner P et al (2009) Vardenafil modulates bladder contractility through cGMP-mediated inhibition of RhoA/Rho kinase signaling pathway in spontaneously hypertensive rats. J Sex Med 6:1594
Behr- Roussel D, Oger S, Caisey S et al (2011) Vardenafil decreases bladder afferent nerve activity in unanesthetized, decerebrate, and spinal cord injured rats. Eur Urol 59:272
Wang S, Mitu G, Hirschberg R (2008) Osmotic polyuria: an overlooked mechanism in diabetic nephropathy. Nephrol Dial Transplant 23:2167
Van Den Eeden S, Ferrara A, Shan J et al (2013) Impact of type 2 diabetes on lower urinary tract symptoms on men: a cohort study. BMC Urol 13:12
Dirección General de Epidemiología. Type 2 diabetes mellitus epidemiological bulletin first trimester-2013. http://www.epidemiologia.salud.gob.mx/doctos/infoepid/bol_diabetes/dm2_bol1_2013.pdf. Accessed 01 Jun 2015
Author contribution
B. Gonzalez-Sanchez and J. Cendejas-Gomez involved in project development, data collection, data analysis, and manuscript writing; J.A. Rivera-Ramirez contributed to data collection, data analysis, and manuscript writing; J.O. Herrera-Caceres involved in data analysis and manuscript writing; D. Olvera-Posada contributed to project development and data collection; C.I. Villeda-Sandoval contributed to project development, data analysis, and manuscript writing; R.A. Castillejos-Molina, G. Feria-Bernal, and A. Garcia-Mora are advisors; F. Rodriguez-Covarrubias involved in project development, data analysis, manuscript writing and supervision.
Author information
Authors and Affiliations
Corresponding author
Additional information
Benjamin Gonzalez-Sanchez and Jesus Cendejas-Gomez have contributed equally to this work.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Gonzalez-Sanchez, B., Cendejas-Gomez, J., Alejandro Rivera-Ramirez, J. et al. The correlation between lower urinary tract symptoms (LUTS) and erectile dysfunction (ED): results from a survey in males from Mexico City (MexiLUTS). World J Urol 34, 979–983 (2016). https://doi.org/10.1007/s00345-015-1703-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00345-015-1703-4